NIH Secures FDA Approval for Clinical Trials on Novel Opioid Treatment
The NIH has received FDA approval for clinical trials evaluating mitragynine as an opioid treatment. This initiative highlights new procurement opportunities for organizations specializing in clinical trial management and drug development.